1. Home
  2. RCMT vs RANI Comparison

RCMT vs RANI Comparison

Compare RCMT & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$20.97

Market Cap

144.7M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
RANI
Founded
1971
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.7M
134.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RCMT
RANI
Price
$20.97
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$30.00
$8.67
AVG Volume (30 Days)
45.6K
2.6M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$309,840,000.00
$1,200,000.00
Revenue This Year
$15.20
$414.59
Revenue Next Year
$7.50
$30.15
P/E Ratio
$12.25
N/A
Revenue Growth
13.70
N/A
52 Week Low
$13.18
$0.39
52 Week High
$28.27
$3.87

Technical Indicators

Market Signals
Indicator
RCMT
RANI
Relative Strength Index (RSI) 54.94 44.17
Support Level $20.59 $1.34
Resistance Level $21.58 $1.67
Average True Range (ATR) 0.74 0.13
MACD 0.30 -0.03
Stochastic Oscillator 78.45 27.94

Price Performance

Historical Comparison
RCMT
RANI

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: